In vitro and in vivo hypoglycemic effects of brown algal fucoidans

International Journal of Biological Macromolecules

Volumn 82, Issue , 2016, Pages 249-255

  Shan, Xindi ^a,b   Liu, Xin ^a,b   Hao, Jiejie ^a,b   Cai, Chao ^a,b   Fan, Fei ^a,b   Dun, Yunlou ^a,b   Zhao, Xiaoliang ^a,b   Liu, Xiaoxiao ^a,b   Li, Chunxia ^a,b   Yu, Guangli ^a,b  

^a Laboratory for Marine Science and Technology   (China)

^b OCEAN UNIVERSITY OF CHINA   (China)

Author keywords

Fucoidan; In vitro and in vivo studies; Glucosidase

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE; AMYLASE; FUCOIDIN; FUCOSE; GLUCOSE; HEMOGLOBIN A1C; ANTIDIABETIC AGENT; ENZYME INHIBITOR; GLUCOSE BLOOD LEVEL; POLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; BROWN ALGA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; DRUG POTENCY; ENZYME INHIBITION; FUCUS VESICULOSUS; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; IC50; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MTT ASSAY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; SEAWEED; STRUCTURE ACTIVITY RELATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; EPITHELIUM CELL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ALPHA-AMYLASES; ALPHA-GLUCOSIDASES; ANIMALS; BLOOD GLUCOSE; CELL SURVIVAL; ENZYME INHIBITORS; EPITHELIAL CELLS; HYPOGLYCEMIC AGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; PHAEOPHYTA; POLYSACCHARIDES; RATS; SEAWEED;

EID: 84952638179     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2015.11.036     Document Type: Article

References (48)

1. Sarwar N., Gao P., Seshasai S.R., Gobin R., Kaptoge S., Di Angelantonio E., Ingelsson E., Lawlor D.A., Selvin E., Stampfer M., Stehouwer C.D., Lewington S., Pennells L., Thompson A., Sattar N., White I.R., Ray K.K., Danesh J. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010, 375:2215-2222.
2. Malik V.S., Popkin B.M., Bray G.A., Despres J.P., Hu F.B. Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 2010, 121:1356-1364.
3. Su C.H., Lai M.N., Ng L.T. Inhibitory effects of medicinal mushrooms on alpha-amylase and alpha-glucosidase-enzymes related to hyperglycemia. Food Funct. 2013, 4:644-649.
4. Levetan C.S., Pierce S.M. Distinctions between the islets of mice and men: implications for new therapies for type 1 and 2 diabetes. Endocr. Pract. 2013, 19:301-312.
5. Li B., Lu F., Wei X., Zhao R. Fucoidan: structure and bioactivity. Molecules 2008, 13:1671-1695.
6. Jiao G., Yu G., Zhang J., Ewart H.S. Chemical structures and bioactivities of sulfated polysaccharides from marine algae. Mar. Drugs 2011, 9:196-223.
7. Cumashi A., Ushakova N.A., Preobrazhenskaya M.E., D'Incecco A., Piccoli A., Totani L., Tinari N., Morozevich G.E., Berman A.E., Bilan M.I., Usov A.I., Ustyuzhanina N.E., Grachev A.A., Sanderson C.J., Kelly M., Rabinovich G.A., Iacobelli S., Nifantiev N.E. A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology 2007, 17:541-552.
8. Kim K.J., Lee O.H., Lee B.Y. Fucoidan, a sulfated polysaccharide, inhibits adipogenesis through the mitogen-activated protein kinase pathway in 3T3-L1 preadipocytes. Life Sci. 2010, 86:791-797.
9. Kim M., Chang U., Lee J. Inhibitory effects of fucoidan in 3T3-L1 adipocyte differentiation. Mar. Biotechnol. 2009, 11:557-562.
10. Kim K.J., Yoon K.Y., Lee B.Y. Fucoidan regulate blood glucose homeostasis in C57BL/KSJ m+/+db and C57BL/KSJ db/db mice. Fitoterapia 2012, 83:1105-1109.
11. Thomes P., Rajendran M., Pasanban B., Rengasamy R. Cardioprotective activity of Cladosiphon okamuranus fucoidan against isoproterenol induced myocardial infarction in rats. Phytomedicine 2010, 18:52-57.
12. Kim K., Rioux L., Turgeon S.L. Alpha-amylase and alpha-glucosidase inhibition is differentially modulated by fucoidan obtained from Fucus vesiculosus and Ascophyllum nodosum. Phytochemistry 2014, 98:27-33.
13. Vinoth Kumar T., Lakshmanasenthil S., Geetharamani D., Marudhupandi T., Suja G., Suganya P. Fucoidan-A α-d-glucosidase inhibitor from Sargassum wightii with relevance to type 2 diabetes mellitus therapy. Int. J. Biol. Macromol. 2015, 72:1044-1047.
14. Fu D.T., Oneill R.A. Monosaccharide composition analysis of oligosaccharides and glycoproteins by high-performance liquid chromatography. Anal. Biochem. 1995, 227:377-384.
15. Nampoothiri S.V., Prathapan A., Cherian O.L., Raghu K.G., Venugopalan V.V., Sundaresan A. In vitro antioxidant and inhibitory potential of Terminalia bellerica and Emblica officinalis fruits against LDL oxidation and key enzymes linked to type 2 diabetes. Food Chem. Toxicol. 2011, 49:125-131.
16. Cho M., Han J.H., You S. Inhibitory effects of fucan sulfates on enzymatic hydrolysis of starch. LWT-Food Sci. Technol. 2011, 44:1164-1171.
17. Funke I., Melzig M.F. Effect of different phenolic compounds on α-amylase activity: screening by microplate-reader based kinetic assay. Die Pharmazie-Int. J. Pharm. Sci. 2005, 60:796-797.
18. McDougall G.J., Shpiro F., Dobson P., Smith P., Blake A., Stewart D. Different polyphenolic components of soft fruits inhibit α-amylase and α-glucosidase. J. Agric. Food Chem. 2005, 53:2760-2766.
19. Hossain S.J., Tsujiyama I., Takasugi M., Islam M.A., Biswas R.S., Aoshima H. Total phenolic content, antioxidative, anti-amylase, anti-glucosidase and antihistamine release activities of Bangladeshi fruits. Food Sci. Technol. Res. 2008, 14:261-268.
20. Lakshmanasenthil S., Vinothkumar T., Geetharamani D., Marudhupandi T., Suja G., Sindhu N.S. Fucoidan-a novel α-amylase inhibitor from Turbinaria ornata with relevance to NIDDM therapy. Biocatal. Agric. Biotechnol. 2014, 3:66-70.
21. Black W. The seasonal variation in the combined l-fucose content of the common British Laminariaceae and fucaceae. J. Sci. Food Agric. 1954, 5:445-448.
22. Apostolidis E., Karayannakidis P.D., Kwon Y.I., Lee C.M., Seeram N.P. Seasonal variation of phenolic antioxidant-mediated alpha-glucosidase inhibition of Ascophyllum nodosum. Plant Foods Hum. Nutr. 2011, 66:313-319.
23. Schäfer A., Högger P. Oligomeric procyanidins of French maritime pine bark extract (Pycnogenol®) effectively inhibit α-glucosidase. Diabetes Res. Clin. Pr. 2007, 77:41-46.
24. Zhang Z., Till S., Jiang C., Knappe S., Reutterer S., Scheiflinger F., Szabo C.M., Dockal M. Structure-activity relationship of the pro- and anticoagulant effects of Fucus vesiculosus fucoidan. Thromb. Haemost. 2014, 111:429-437.
25. Clement M.J., Tissot B., Chevolot L., Adjadj E., Du Y., Curmi P.A., Daniel R. NMR characterization and molecular modeling of fucoidan showing the importance of oligosaccharide branching in its anticomplementary activity. Glycobiology 2010, 20:883-894.
26. Patankar M.S., Oehninger S., Barnett T., Williams R.L., Clark G.F. A revised structure for fucoidan may explain some of its biological activities. J. Biol. Chem. 1993, 268:21770.
27. Bilan M.I., Grachev A.A., Ustuzhanina N.E., Shashkov A.S., Nifantiev N.E., Usov A.I. Structure of a fucoidan from the brown seaweed Fucus evanescens C.Ag. Carbohydr. Res. 2002, 337:719-730.
28. Chevolot L., Mulloy B., Ratiskol J., Foucault A., Colliec-Jouault S. A disaccharide repeat unit is the major structure in fucoidans from two species of brown algae. Carbohydr. Res. 2001, 330:529-535.
29. Lee J., Takeshita A., Hayashi K., Hayashi T. Structures and antiviral activities of polysaccharides from Sargassum trichophyllum. Carbohyd. Polym. 2011, 86:995-999.
30. Duarte M.E., Cardoso M.A., Noseda M.D., Cerezo A.S. Structural studies on fucoidans from the brown seaweed Sargassum stenophyllum. Carbohydr. Res. 2001, 333:281-293.
31. Thinh P.D., Menshova R.V., Ermakova S.P., Anastyuk S.D., Ly B.M., Zvyagintseva T.N. Structural characteristics and anticancer activity of fucoidan from the brown alga Sargassum mcclurei. Mar. Drugs 2013, 11:1456-1476.
32. Chandia N.P., Matsuhiro B. Characterization of a fucoidan from Lessonia vadosa (Phaeophyta) and its anticoagulant and elicitor properties. Int. J. Biol. Macromol. 2008, 42:235-240.
33. Sakai T., Kimura H., Kojima K., Shimanaka K., Ikai K., Kato I. Marine bacterial sulfated fucoglucuronomannan (SFGM) lyase digests brown algal SFGM into trisaccharides. Mar. Biotechnol. (NY) 2003, 5:70-78.
34. Ermakova S., Sokolova R., Kim S.M., Um B.H., Isakov V., Zvyagintseva T. Fucoidans from brown seaweeds Sargassum hornery, Eclonia cava, Costaria costata: structural characteristics and anticancer activity. Appl. Biochem. Biotechnol. 2011, 164:841-850.
35. Mosi R., Sham H., Uitdehaag J.C.M., Ruiterkamp R., Dijkstra B.W., Withers S.G. Reassessment of acarbose as a transition state analogue inhibitor of cyclodextrin glycosyltransferase. Biochemistry-US 1998, 37:17192-17198.
36. Hsiao S.H., Liao L.H., Cheng P.N., Wu T.J. Hepatotoxicity associated with acarbose therapy. Ann. Pharmacother. 2006, 40:151-154.
37. Kono T., Hayami M., Kobayashi H., Ishii M., Taniguchi S. Acarbose-induced generalised erythema multiforme. Lancet 1999, 354:396-397.
38. Nishii Y., Aizawa T., Hashizume K. Ileus: a rare side effect of acarbose. Diabetes Care 1996, 19:1033.
39. Liu Q.S., Liu Y., Show K.Y., Tay J.H. Toxicity effect of phenol on aerobic granules. Environ. Technol. 2009, 30:69-74.
40. Tay S.T., Moy B.Y., Jiang H.L., Tay J.H. Rapid cultivation of stable aerobic phenol-degrading granules using acetate-fed granules as microbial seed. J. Biotechnol. 2005, 115:387-395.
41. Nemeikaite-Ceniene A., Imbrasaite A., Sergediene E., Cenas N. Quantitative structure-activity relationships in prooxidant cytotoxicity of polyphenols: role of potential of phenoxyl radical/phenol redox couple. Arch. Biochem. Biophys. 2005, 441:182-190.
42. Lordan S., Smyth T.J., Soler-Vila A., Stanton C., Ross R.P. The alpha-amylase and alpha-glucosidase inhibitory effects of Irish seaweed extracts. Food Chem. 2013, 141:2170-2176.
43. Diaz-Rubio M.E., Perez-Jimenez J., Saura-Calixto F. Dietary fiber and antioxidant capacity in Fucus vesiculosus products. Int. J. Food Sci. Nutr. 2009, 60(Suppl 2):23-34.
44. Koivikko R., Loponen J., Pihlaja K., Jormalainen V. High-performance liquid chromatographic analysis of phlorotannins from the brown alga Fucus vesiculosus. Phytochem. Anal. 2007, 18:326-332.
45. Zaragoza M.C., Lopez D., S.M.P, Poquet M., Perez J., Puig-Parellada P., Marmol F., Simonetti P., Gardana C., Lerat Y., Burtin P., Inisan C., Rousseau I., Besnard M., Mitjavila M.T. Toxicity and antioxidant activity in vitro and in vivo of two Fucus vesiculosus extracts. J. Agric. Food. Chem. 2008, 56:7773-7780.
46. Simon S.F., Taylor C.G. Dietary zinc supplementation attenuates hyperglycemia in db/db mice. Exp. Biol. Med. (Maywood) 2001, 226:43-51.
47. Young A.A., Gedulin B.R., Bhavsar S., Bodkin N., Jodka C., Hansen B., Denaro M. Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta). Diabetes 1999, 48:1026-1034.
48. Zhang Y., Hu G., Yuan Z., Chen L. Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysis. PLoS ONE 2012, 7:e42551.